drugset / Trial / NCT00239863

Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients

NCT00239863

Phase 3 Completed 684 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the safety and efficacy of FTY720 versus mycophenolate mofetil (MMF, Roche brand) combined with cyclosporine and corticosteroids in patients receiving a kidney transplant.

Timeline

Start
2004-05
Primary completion
2006-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fingolimod Small molecule

Indications

No indication recorded.